Zalicus Inc - ZLCS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Zalicus Inc - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ZLCS	Nasdaq	2834	http://www.zalicus.com/	0.595 -0.0049
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Zalicus Inc ZALICUS INC. Financials - May 17th, 2013 11:04 am Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain - May 10th, 2013 6:45 am ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 9th, 2013 11:50 pm Zalicus Secures New $25 Million Funding Commitment from Lincoln Park Capital - May 8th, 2013 6:30 am ZALICUS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - May 7th, 2013 11:35 pm ZALICUS INC. Files SEC form 10-Q, Quarterly Report - May 3rd, 2013 7:08 am Watching Zalicus Like A Hawk - May 2nd, 2013 11:39 am 2 Biotechs Primed For Prosperity In 2013 - May 2nd, 2013 10:09 am Zalicus Reports Financial Results for the First Quarter 2013 - May 2nd, 2013 5:30 am ZALICUS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - May 1st, 2013 10:37 pm ZALICUS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Apr 30th, 2013 11:00 pm ZALICUS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran - Apr 18th, 2013 11:31 pm ZALICUS INC. Files SEC form 8-K, Change in Directors or Principal Officers - Apr 10th, 2013 11:30 pm For Zalicus The Renewal Of Its Partnership With Novartis Will Be Vital For FY '13 Revenues - Apr 3rd, 2013 5:25 am 4 Healthcare Stock Stories for Tuesday Investment Wellness - Apr 2nd, 2013 12:18 pm Zalicus grantes patent covering formulations of Z160 - Apr 2nd, 2013 6:02 am Zalicus Granted Key Formulation Patent for Z160 - Apr 2nd, 2013 6:00 am ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - Apr 1st, 2013 11:06 pm AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar - Mar 19th, 2013 6:32 am Zalicus presents data on state-dependent ion channel screening - Mar 19th, 2013 6:02 am View All Current Headlines >>